Centre for Infectious Disease Control Netherlands (Cib), National Institute for Public Health and the Environment (RIVM), Bilthoven.
European Programme for Intervention Epidemiology Training, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Clin Infect Dis. 2020 May 6;70(10):2036-2044. doi: 10.1093/cid/ciz578.
An increase in invasive meningococcal disease (IMD) serogroup W (IMD-W) cases caused by sequence type-11 clonal complex (cc11) was observed from October 2015 in the Netherlands. We compared the clinical picture and disease outcome of IMD-W cases with other serogroups, adjusting for host characteristics.
We included IMD cases reported from January 2015 to June 2018 in the Netherlands and assessed clinical manifestation and symptoms at disease onset and calculated case fatality rates (CFRs). We used logistic regression to compare clinical manifestations and mortality of IMD-W with IMD caused by meningococci serogroup B, Y, or C, adjusting for age, gender, and comorbidities.
A total of 565 IMD cases were reported, of which 204 were IMD-W, 270 IMD-B, 63 IMD-Y, and 26 IMD-C. Most IMD-W isolates belonged to cc11 (93%; 175/188). Compared with other serogroups, IMD-W patients were diagnosed more often with septicemia (46%) or pneumonia (12%) and less often with meningitis (17%, P < .001). IMD-W cases presented more often with respiratory symptoms (45%, P < .001); 16% of IMD-W patients presented with diarrhea without IMD-specific symptoms (P = .061). The CFR for IMD-W was 16% (32/199, P < .001). The differences between IMD-W and other serogroups remained after adjusting for age, gender, and comorbidities.
The atypical presentation and severe outcome among IMD-W cases could not be explained by age, gender, and comorbidities. Almost all our IMD-W cases were caused by cc11. More research is needed to identify the bacterial factors involved in clinical presentation and severity of IMD-W cc11.
自 2015 年 10 月以来,荷兰观察到由序列型 11 克隆复合体(cc11)引起的侵袭性脑膜炎奈瑟菌病(IMD)血清群 W(IMD-W)病例有所增加。我们比较了 IMD-W 病例与其他血清群的临床表现和疾病结局,并调整了宿主特征。
我们纳入了 2015 年 1 月至 2018 年 6 月期间在荷兰报告的 IMD 病例,并评估了疾病发病时的临床表现和症状,并计算了病例死亡率(CFR)。我们使用逻辑回归比较了 IMD-W 与由脑膜炎奈瑟菌血清群 B、Y 或 C 引起的 IMD 的临床表现和死亡率,调整了年龄、性别和合并症。
共报告了 565 例 IMD 病例,其中 204 例为 IMD-W、270 例为 IMD-B、63 例为 IMD-Y 和 26 例为 IMD-C。大多数 IMD-W 分离株属于 cc11(93%,175/188)。与其他血清群相比,IMD-W 患者更常被诊断为败血症(46%)或肺炎(12%),而脑膜炎(17%)较少(P<0.001)。IMD-W 病例更常出现呼吸道症状(45%,P<0.001);16%的 IMD-W 患者出现腹泻而无 IMD 特异性症状(P=0.061)。IMD-W 的 CFR 为 16%(32/199,P<0.001)。调整年龄、性别和合并症后,IMD-W 与其他血清群之间的差异仍然存在。
IMD-W 病例的非典型表现和严重结局不能用年龄、性别和合并症来解释。我们几乎所有的 IMD-W 病例都是由 cc11 引起的。需要进一步研究以确定 IMD-W cc11 临床表型和严重程度相关的细菌因素。